Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Immunoproteomics of Brucella abortus reveals potential of recombinant antigens for discriminating vaccinated from naturally infected cattle

Microb Pathog. 2020; 
Angélica Rosa Faria, Elaine Maria Seles Dorneles, Simone da Fonseca Pires, Hélida Monteiro de Andrade, Andrey Pereira Lage
Products/Services Used Details Operation
Gene Synthesis … showed potential to serologically differentiate cattle vaccinated from those naturally infected by B. abortus (Table 1). So, three synthetic genes, referring to these three differentially reactive proteins of B. abortus 2308, were commercially synthesized by Genscript, USA … Get A Quote

摘要

Brucellosis serodiagnosis is still a challenge and vaccination is the main measure used to control bovine brucellosis, being S19 and RB51 the most currently used vaccines. So, in order to contribute to brucellosis control, a bidimensional (2D) immunoblot-based approach was used to find immunogenic proteins to be used in serodiagnosis, particularly with ability to be employed in DIVA (Differentiating Infected from Vaccinated Animals) strategy. Immunoproteomic profile of Brucella abortus 2308 was analyzed in 2D western blotting using pooled sera from S19 vaccinated animals, RB51 vaccinated animals, B. abortus naturally infected animals and non-vaccinated seronegative animals. Evaluation of the antigens differenti... More

关键词

Bovine brucellosis, DIVA, Diagnosis, Recombinant proteins
XML 地图